{ "items": [ "\n\n
\n \n 23 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nOur researchers discover new evidence that post-brain injury sleep problems can slow the pace of recovery.
\n \n\n\n \n 11 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n \n \nAn international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
\n \n\n\n \n 10 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nAs part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
\n \n\n\n \n 29 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers including Stuart McKechnie and Matthew Rowland from our Critical Care Research Group are carrying out a new drug trial aimed at treating COVID-19, funded by LifeArc.
\n \n\n\n \n 28 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nPost-doctoral Researcher Michiel Cottaar summarises a departmental seminar by Associate Professor Jesper Andersson
\n \n\n\n \n 13 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Academy of Medical Sciences has today announced the election of fifty new Fellows, including Professor David Bennett and Professor Peter Brown.
\n \n\n\n \n 1 May 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA team of our neuroimaging researchers will lead this study, which has received a grant from the University of Oxford's COVID-19 Research Response Fund.
\n \n\n\n \n 30 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNDCN researchers lead a global study based on analysing survey data
\n \n\n\n \n 27 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n \n \nRoyal Society Publishing has recently brought out a special issue of 'Interface Focus' on sleep and stress, past and present
\n \n\n\n \n 14 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearch carried out by George Tofaris and his team has led to the development of a new way to test for Parkinson\u2019s disease before the main symptoms occur. This could allow clinicians to identify patients who would benefit from precision therapies that are currently at clinical trial stage.
\n \n\n\n \n 7 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs.
\n \n\n\n \n 6 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Event\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Alexander Davies summarises a departmental seminar by Dr Simon Rinaldi
\n \n\n\n \n 6 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n Coronavirus\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n \n \nNHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.
\n \n\n\n \n 1 April 2020\n \n
\n\n \n\n \n\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are pleased to announce that today the University of Oxford MRC Brain Network Dynamics Unit joins the Nuffield Department of Clinical Neurosciences (NDCN) as a sixth division.
\n \n\n\n \n 6 March 2020\n \n
\n\n \n\n \n\n \n \n \n \n Event\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nResearch into strokes and vascular dementia took a major step forward on Thursday 5 March with the official opening of our Wolfson Centre for the Prevention of Stroke and Dementia (CPSD) based at the new Wolfson Building.
\n \n\n\n \n 27 February 2020\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
\n \n\n\n \n 18 February 2020\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n\u00a3277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.
\n \n\n\n \n 17 January 2020\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Stroke & Dementia\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.
\n \n\n\n \n 17 January 2020\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Arjune Sen is leading a new six-month trial funded by the MRC Confidence in Concept scheme. The study is known as IliAD (Investigation of Levetiracetam in Alzheimer's Disease).
\n \n\n\n \n 11 November 2019\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNDCN\u2019s Associate Professor Andrea Nemeth is leading the Oxford part of a clinical trial for Hungtinton\u2019s disease.
\n \n\n